Association of plasma and synovial fluid interferon-γ inducible protein-10 with radiographic severity in knee osteoarthritis

Clinical Biochemistry

Volumn 44, Issue 14-15, 2011, Pages 1218-1222

  Saetan, Natthaphon ^a   Honsawek, Sittisak ^a   Tanavalee, Aree ^b   Tantavisut, Saran ^b   Yuktanandana, Pongsak ^b   Parkpian, Vinai ^b  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Disease severity; Interferon inducible protein 10; Osteoarthritis; Plasma; Synovial fluid

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNOVIAL FLUID LEVEL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

EID: 80052957256     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.07.010     Document Type: Article

References (39)

1. Krasnokutsky S., Attur M., Palmer G., Samuels J., Abramson S.B. Current concepts in the pathogenesis of osteoarthritis. Osteoarthritis Cartilage 2008, 16:1-3.
2. Lohmander L.S., Lark M.W., Dahlberg L., Walakovits L.A., Roos H. Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine. Clin Biochem 1992, 25:167-174.
3. Ono S.J., Nakamura T., Miyazaki D., Ohbayashi M., Dawson M., Toda M. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol 2003, 111:1185-1200.
4. Laing K.J., Secombes C.J. Chemokines. Dev Comp Immunol 2004, 28:443-460.
5. Szekanecz Z., Kim J., Koch A.E. Chemokines and chemokine receptors in rheumatoid arthritis. Semin Immunol 2003, 15:15-21.
6. Fernandez E.J., Lolis E. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 2002, 42:469-499.
7. Gouwy M., Struyf S., Proost P., Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005, 16:561-580.
8. Szekanecz Z., Strieter R.M., Kunkel S.L., Koch A.E. Chemokines in rheumatoid arthritis. Springer Semin Immunopathol 1998, 20:115-132.
9. Korniejewska A., Watson M., Ward S. Analysis of CXCR3 and atypical variant expression and signalling in human T lymphocytes. Methods Mol Biol 2010, 616:125-147.
10. Scanzello C.R., McKeon B., Swaim B.H., et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum 2011, 63:391-400.
11. García-Arnandis I., Guillén M.I., Gomar F., Pelletier J.P., Martel-Pelletier J., Alcaraz M.J. High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther 2010, 12:R165.
12. Erdem H., Pay S., Musabak U., et al. Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?. Rheumatol Int 2007, 27:969-973.
13. Hanaoka R., Kasama T., Muramatsu M., et al. A novel mechanism for the regulation of IFN-gamma inducible protein-10 expression in rheumatoid arthritis. Arthritis Res Ther 2003, 5:R74-R81.
14. Honsawek S., Chayanupatkul M., Tanavalee A., et al. Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study. Int Orthop 2009, 33:1171-1175.
15. Honsawek S., Tanavalee A., Sakdinakiattikoon M., Chayanupatkul M., Yuktanandana P. Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem 2009, 42:808-812.
16. Chayanupatkul M., Honsawek S. Soluble receptor for advanced glycation end products (sRAGE) in plasma and synovial fluid is inversely associated with disease severity of knee osteoarthritis. Clin Biochem 2010, 43:1133-1137.
17. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
18. Berg L.C., Lenz J., Kjelgaard-Hansen M., Thomsen P.D., Jacobsen S. Cartilage-derived retinoic acid-sensitive protein in equine synovial fluid from healthy and diseased joints. Equine Vet J 2008, 40:553-557.
19. Neville L.F., Mathiak G., Bagasra O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev 1997, 8:207-219.
20. Huss R.S., Huddleston J.I., Goodman S.B., Butcher E.C., Zabel B.A. Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation. Arthritis Rheum 2010, 62:3799-3805.
21. Ruschpler P., Lorenz P., Eichler W., et al. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther 2003, 5:R241-R252.
22. Kuan W.P., Tam L.S., Wong C.K., et al. CXCL 9 and CXCL 10 as sensitive markers of disease activity in patients with rheumatoid arthritis. J Rheumatol 2010, 37:257-264.
23. Antonelli A., Fallahi P., Delle Sedie A., et al. High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol 2009, 27:22-27.
24. Antonelli A., Fallahi P., Delle Sedie A., et al. High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis. Autoimmunity 2008, 41:537-542.
25. De Ceuninck F., Dassencourt L., Anract P. The inflammatory side of human chondrocytes unveiled by antibody microarrays. Biochem Biophys Res Commun 2004, 323:960-969.
26. Endres M., Andreas K., Kalwitz G., et al. Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Osteoarthritis Cartilage 2010, 18:1458-1466.
27. Patel D.D., Zachariah J.P., Whichard L.P. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol 2001, 98:39-45.
28. de Jager W., Hoppenreijs E.P., Wulffraat N.M., Wedderburn L.R., Kuis W., Prakken B.J. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 2007, 66:589-598.
29. Wu H.X., Zhang Y., Zhu Y.L. Serum levels of several chemokines in patients with rheumatoid arthritis. Zhonghua Yi Xue Za Zhi 2005, 85:534-537.
30. Goldring M.B., Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 2004, 427S:S37-S46.
31. Lohmander L.S., Brandt K.D., Mazzuca S.A., et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum 2005, 52:3160-3167.
32. Stannus O., Jones G., Cicuttini F., et al. Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 2010, 18:1441-1447.
33. Neidhart M., Hauser N., Paulsson M., DiCesare P.E., Michel B.A., Häuselmann H.J. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997, 36:1151-1160.
34. Sharif M., Saxne T., Shepstone L., et al. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 1995, 34:306-310.
35. Vilím V., Olejárová M., Machácek S., Gatterová J., Kraus V.B., Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 2002, 10:707-713.
36. Williams F.M., Spector T.D. Biomarkers in osteoarthritis. Arthritis Res Ther 2008, 10:101.
37. Pavelka K., Forejtová S., Olejárová M., et al. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage 2004, 12:277-283.
38. Elliott A.L., Kraus V.B., Luta G., et al. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 2005, 52:105-111.
39. Golightly Y.M., Marshall S.W., Kraus V.B., et al. Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms?. Arthritis Rheum 2011, 63:2276-2283.